ADJUVANT THERAPY DURING SURGICAL TREATMENT OF LIVER ECHINOCOCCOSIS
Keywords:
liver echinococcosis, albendazole, prevention, relapse.Abstract
Objective: To determine the effect of albendazole on the viability of protoscolexes and the frequency of relapses of echinococcal liver disease.
Methods: The study was conducted in the surgical department of the multidisciplinary clinic of the Samarkand State Medical University, for 4 years from 2014 to 2017, with further follow-up for 5 years. The study included 86 cases in the age group of 17-66 years. The patients were divided into two groups of 43 people each. In the comparison group, patients were directly operated on, while in the main group, patients were prescribed albendazole for 12 weeks before surgery, followed by a postoperative course for 12 weeks.
Results: Among patients treated with albendazole, no patient had viable cysts at the time of surgery compared to 93.1% of patients who did not receive albendazole before surgery (P<0.01). In patients not treated with albendazole, the relapse rate was 18.6%, while in patients treated with albendazole, no relapse was observed (P≤0.05).
Conclusions: We concluded that albendazole is an effective adjuvant therapy in the treatment of Echinococcal liver disease.
References
Аничкин В. В., Повелица Э. А., Мартынюк В. В. Метод атипичной резекции печени с антипаразитарной обработкой печеночной ткани смесью глицерина и 1-2% раствора альбендазола в димексиде у пациентов с эхинококкозом печени // Новости хирургии. – 2014. – Т. 22. – №. 3. – С. 360-365.
Курбаниязов, З. Б., Рахманов, К. Э., Мизамов, Ф. О., & Анарбоев, С. А. (2022). Роль химиотерапии в профилактике рецидива эхинококкоза печени. Вопросы науки и образования, (6 (162)), 39-50.
Назыров Ф. Г. и др. Химиотерапия и проблемы реиидивного эхинококкоза печени // Анналы хирургической гепатологии. – 2011. – Т. 16. – №. 4. – С. 19-24.
Хайитов И.Б., Аминжанов А.А. Роль и место пункционно-дренажного метода в лечении эхинококкоза печени // Eurasian Journal of Medical and Natural Sciences. – 2022. – Т. 2. – №. 6. – С. 15-25.
Шамсиев А. М., Шамсиев Ж. А., Рахманов К. Э. Коррекция дозы альбендазола после эхинококкэктомии из печени //Детская хирургия. – 2020. – Т. 24. – №. 1. – С. 16-20.
MiLicevic MN. Hydatid disease: Surgery of liver and biliary tract. In: LH Blumgart, Y Fong editors. 3rd ed. London: W B. Saunders Company Ltd; 2000.
Khuroo MS, Dar MY, Yattoo GN, Zargar SA, Javaid G, Khan BA, Percutaneous drainage versus albendazole therapy in hepatic hydatidosis: A prospective randomized study. Gastroenterology 1993;104:1452-59.
Bekthi A, Schapps JP, Capron M. Treatment of hepatic disease with mebendazole; Preliminary results in four cases. Br Med J 1977;2:1047-51.
Morris DL, Gould SE. Serum and cyst concentrations of mebendazole and flubendazole in hydatid disease. Br Med J (Clin Res Ed) 1982;285:175.
Morris DL, Chinnery JB. Penetration of albendazole sulphoxide into hydatid cyst. Gut 1987;28:75-80.
Chinnery JB , Morris DL. Effect of albendazole on viability of hydatid protoscolesces. Trans R Soc Trop Med Hyg 1986;80;815-17.
Teggi A, Lastilla MG, DeRossa F. Therapy of human hydatid disease with mebendazole and albendazole. Antimicrob Ag Chemotherapy 1993;37:1679-84.
Khuroo MS. Hydatid disease: Current status and recent advances. Ann Saudi Med 2002;22:56-64.
Morris DL. Preoperative albendazole therapy for hydatid cyst. Br J Surg 1987;74:805-6.
Horton RJ. Chemotherapy of Echinococcus infection in man with albendazole. Trans of Roy Soc of Trop Med Hyg 1989;83:97-102.
Arif SH, Shams-Ul-Bari, Wani NA, Zargar SA, Wani MA, Tabassum R, et al. Albendazole as an adjuvant to the standard surgical management of hydatid cyst liver. Int J surg Dec 2008;6:448-51.
Evangelos C. Perioperative benzimidazole therapy in human hydatid liver disease. Int Surg 1995;80:131-3.
Mottaghian H, Saidi F. Postoperative recurrence of hydatid disease. Br J Surg 1978:65;237-42.
Little JM, Hollands MT, Eckberg H. Recurrence of hydatid disease. World J Surg 1988;12:700-4.
Morris DL. Albendazole treatment of hydatid disease-follow up at 5 years. Trop Doct 1989;19:179-80.
Мамараджабов, С. Э. Роль и место сероэпидемиологического обследования населения в ранней диагностике эхинококкоза в Самаркандской области / С. Э. Мамараджабов, Ж. А. Ризаев, С. Р. Баймаков // Актуальные аспекты медицинской деятельности : сборник статей I Международной научно-практической конференции, Киров - Самарканд, 21 июня 2021 года. – Киров: Федеральное государственное бюджетное образовательное учреждение высшего образования "Кировский государственный медицинский университет" Министерства здравоохранения Российской Федерации, 2021. – С. 209-212. – EDN DOETDC.
Турсунов О. М. и др. Интервенционные чрескожные технологии в лечении больных с синдромом механической желтухи //Журнал биомедицины и практики. – 2022. – Т. 7. – №. 1
